Interestingly, this TGFβ1-induced cardiac hypertrophy is associated with increased myocardial β-adrenergic receptors (ARs) density (Rosenkranz et al. 2002) and β-AR blockade treatment in TGFβ1 transgenic mice prevents cardiac hypertrophy. The gene discussed is TGFB1; the disease is cardiac hypertrophy.